|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Stroke | |||||
| Ischemic Attack, Transient | |||||
| Cerebral Infarction | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Infarction | |||||
| 3 | More general conditions related to this trial | ||||
| Brain Diseases | |||||
| Brain Infarction | |||||
| Brain Ischemia | |||||
| Cardiovascular Diseases | |||||
| Central Nervous System Diseases | |||||
| Cerebrovascular Disorders | |||||
| Ischemia | |||||
| Necrosis | |||||
| Nervous System Diseases | |||||
| Pathologic Processes | |||||
| Vascular Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| best medical therapy | |||||
| 5 | Sponsors listed in this trial | ||||
| The University of North Carolina, Chapel Hill | |||||
| National Institute of Neurological Disorders and Stroke (NINDS) | |||||
| Washington University School of Medicine | |||||
| University of Iowa | |||||